Bodysync, Inc.
Redondo Beach, CA, US· latest recorded location
BODYSYNC, INC. is named on 0 US grants and 7 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 0
- Published applications
- 7
- Inventors
- 9
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 4 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year.
Technology areas
Share of 7 documents
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6
- A61PTherapeutic uses of medicines3
- A61KMedicines and medical preparations2
- C12YEnzymes2
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- G09BEducational or demonstration appliances1
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or1
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the1
Recent patents
No granted patents yet.
- Methods for determining gene-alpha tocopherol interactions7 Oct 2021US 2021/0310069 A1
- Methods for determining gene-nutrient interactions1 Jun 2017US 2017/0152559 A1
- Susceptibility to bone damage22 Dec 2016US 2016/0369342 A1
- Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture8 Sep 2016US 2016/0258015 A1
- Susceptibility to bone damage28 Jul 2016US 2016/0215339 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.